Evaluating the European Medicines Agency Fee System
The EMA fee system is generally efficient and effective, but it is not cost-based at a granular level and not always flexible, and over time it has become increasingly complex. Additionally the EMA relies on both industry fees and EU and EEA budget contributions to meet the costs of all its activities.
07 Oct 2019